| Literature DB >> 33090237 |
Valentin Jossen1, Dieter Eibl2, Regine Eibl2.
Abstract
Human mesenchymal stem cells (hMSCs) are a valuable source of cells for clinical applications (e.g., treatment of acute myocardial infarction or inflammatory diseases), especially in the field of regenerative medicine. However, for autologous (patient-specific) and allogeneic (off-the-shelf) hMSC-based therapies, in vitro expansion is necessary prior to the clinical application in order to achieve the required cell numbers. Safe, reproducible, and economic in vitro expansion of hMSCs for autologous and allogeneic therapies can be problematic because the cell material is restricted and the cells are sensitive to environmental changes. It is beneficial to collect detailed information on the hydrodynamic conditions and cell growth behavior in a bioreactor system, in order to develop a so called "Digital Twin" of the cultivation system and expansion process. Numerical methods, such as Computational Fluid Dynamics (CFD) which has become widely used in the biotech industry for studying local characteristics within bioreactors or kinetic growth modelling, provide possible solutions for such tasks.In this review, we will present the current state-of-the-art for the in vitro expansion of hMSCs. Different numerical tools, including numerical fluid flow simulations and cell growth modelling approaches for hMSCs, will be presented. In addition, a case study demonstrating the applicability of CFD and kinetic growth modelling for the development of an microcarrier-based hMSC process will be shown.Entities:
Keywords: Computational Fluid Dynamics; Euler-Euler model; Euler-Lagrange model; Human mesenchymal stem cells; Kinetic growth modelling; Microcarrier technology; Single-use bioreactor
Mesh:
Year: 2021 PMID: 33090237 DOI: 10.1007/10_2020_147
Source DB: PubMed Journal: Adv Biochem Eng Biotechnol ISSN: 0724-6145 Impact factor: 2.635